RISK ASSESSMENT OF HEPATOCELLULAR CARCINOMA (HCC) AND/OR LIVER RELATED COMPLICATIONS (LRC) USING FIBROSIS STAGING BY LIVER STIFFNESS MEASUREMENT (LSM) OR LIVER BIOPSY IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) PATIENTS WITH ADVANCED FIBROSIS

被引：0
|
作者：
Anancheunsook, Prooksa
Pitisuttithum, Panyavee
Chaiteerakij, Roongruedee
Komolmit, Piyawat
Treeprasertsuk, Sombat
机构：
来源：
GASTROENTEROLOGY | 2020年 / 158卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1510
引用
收藏
页码：S1432 / S1432
页数：1
相关论文
共 50 条
  • [31] Risk of Nonalcoholic Fatty Liver Disease (NAFLD)-Related Liver Complications in the Diabetic Population in Israel
    Goldshtein, Inbal
    Fernandes, Gail
    Chodick, Gabriel
    Rajpathak, Swapnil
    Karasik, Avraham
    DIABETES, 2018, 67
  • [32] ASSOCIATION BETWEEN LONGITUDINAL CHANGES IN MARKERS OF LIVER FIBROSIS AND RISK FOR HEPATOCELLULAR CARCINOMA IN NONALCOHOLIC FATTY LIVER DISEASE
    Cholankeril, George
    Kramer, Jennifer
    Chu, Jinna
    Yu, Xian
    El-Serag, Hashem B.
    Kanwal, Fasiha
    HEPATOLOGY, 2021, 74 : 615A - 616A
  • [33] Advanced Liver Fibrosis Predicts CKD Development in Patients with Nonalcoholic Fatty Liver Disease
    Jung, Chan-Young
    Kim, Hyung Woo
    Kim, Beom Seok
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 687 - 687
  • [34] Exam 2: Optimizing Use of Nonalcoholic Fatty Liver Disease Fibrosis Score, Fibrosis-4 Score, and Liver Stiffness Measurement to Identify Patients With Advanced Fibrosis
    不详
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (12) : E147 - E148
  • [35] ADVANCED LIVER FIBROSIS AND OBESITY ARE PRIMARY RISK FACTORS FOR LONG-TERM OUTCOMES IN PATIENTS WITH BIOPSY-PROVEN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)
    Lam, Robert
    Jain, Dhanpat
    Deng, Yanhong
    Ciarleglio, Maria
    Lim, Joseph K.
    GASTROENTEROLOGY, 2022, 162 (07) : S576 - S576
  • [36] Liver fibrosis is associated with carotid atherosclerosis in patients with liver biopsy-proven nonalcoholic fatty liver disease
    Arai, Taeang
    Atsukawa, Masanori
    Tsubota, Akihito
    Kato, Keizo
    Abe, Hiroshi
    Ono, Hirotaka
    Kawano, Tadamichi
    Yoshida, Yuji
    Tanabe, Tomohide
    Okubo, Tomomi
    Hayama, Korenobu
    Nakagawa-Iwashita, Ai
    Itokawa, Norio
    Kondo, Chisa
    Kaneko, Keiko
    Emoto, Naoya
    Nagao, Mototsugu
    Inagaki, Kyoko
    Fukuda, Izumi
    Sugihara, Hitoshi
    Iwakiri, Katsuhiko
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [37] Liver fibrosis is associated with carotid atherosclerosis in patients with liver biopsy-proven nonalcoholic fatty liver disease
    Taeang Arai
    Masanori Atsukawa
    Akihito Tsubota
    Keizo Kato
    Hiroshi Abe
    Hirotaka Ono
    Tadamichi Kawano
    Yuji Yoshida
    Tomohide Tanabe
    Tomomi Okubo
    Korenobu Hayama
    Ai Nakagawa-Iwashita
    Norio Itokawa
    Chisa Kondo
    Keiko Kaneko
    Naoya Emoto
    Mototsugu Nagao
    Kyoko Inagaki
    Izumi Fukuda
    Hitoshi Sugihara
    Katsuhiko Iwakiri
    Scientific Reports, 11
  • [38] INCIDENCE AND CLINICAL CHARACTERISTICS OF HEPATOCELLULAR CARCINOMA ASSOCIATED WITH NONALCOHOLIC FATTY LIVER DISEASE WITHOUT CIRRHOSIS OR ADVANCED LIVER FIBROSIS
    Behari, Jaideep
    Wang, Renwei
    Luu, Hung N.
    Paragomi, Pedram
    Yu, Yi-Chuan
    Molinari, Michele
    Chopra, Kapil B.
    Malik, Shahid M.
    Geller, David A.
    Yuan, Jian-Min
    HEPATOLOGY, 2021, 74 : 90A - 90A
  • [39] Diabetes Liver Fibrosis Score to Detect Advanced Fibrosis in Diabetics with Nonalcoholic Fatty Liver Disease
    Singh, Amandeep
    Garg, Rajat
    Lopez, Rocio
    Alkhouri, Naim
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (03) : E624 - E626
  • [40] Noninvasive Assessment of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
    Buzzetti, Elena
    Lombardi, Rosa
    De Luca, Laura
    Tsochatzis, Emmanuel A.
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2015, 2015
12345